Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kyle

Showing results (831-840 of 874) with videos related to

Pageof 88
Sort By:
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Blood Advances|June 29, 2019
Impact of acquired del(17p) in multiple myelomaArjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
Blood Advances|May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal|March 9, 2019
Natural history of multiple myeloma with de novo del(17p)Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Race and outcomes of autologous hematopoietic cell transplantation for multiple myelomaParameswaran N Hari, Navneet S Majhail, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR studyDonna E Reece, David H Vesole, Smriti Shrestha, et al.
Mayo Clinic Proceedings|March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted TherapyDavid Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Blood Cancer Journal|February 1, 2022
A simple additive staging system for newly diagnosed multiple myelomaNadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Leukemia|September 2, 2017
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trialS Ailawadhi, J R Mikhael, B R LaPlant, et al.
Pageof 88

Showing results (831-840 of 874) with videos related to

Sort By:
Pageof 88
Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.
Blood Advances|June 29, 2019
Impact of acquired del(17p) in multiple myelomaArjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
Blood Advances|May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myelomaPatrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal|March 9, 2019
Natural history of multiple myeloma with de novo del(17p)Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology|October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosisMatthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Race and outcomes of autologous hematopoietic cell transplantation for multiple myelomaParameswaran N Hari, Navneet S Majhail, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR studyDonna E Reece, David H Vesole, Smriti Shrestha, et al.
Mayo Clinic Proceedings|March 15, 2017
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted TherapyDavid Dingli, Sikander Ailawadhi, P Leif Bergsagel, et al.
Blood Cancer Journal|February 1, 2022
A simple additive staging system for newly diagnosed multiple myelomaNadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Leukemia|September 2, 2017
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trialS Ailawadhi, J R Mikhael, B R LaPlant, et al.
Pageof 88